Clinical Trial Update: TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients [Phase 2]

View source ↗

Summary

A Phase II clinical trial of TGRX-678 in Chinese patients with chronic myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• TGRX-678

Snippet

Sponsor: Shenzhen TargetRx Co., Ltd. | Conditions: Chronic Myeloid Leukemia, Accelerated Phase CML | Phase 2 | Status: RECRUITING